Bin‐Bing S. Zhou
0000-0001-8819-5719
Publication & Citation Trends
Most Cited Works
Publications
65 total
PRMT5 deficiency in myeloid cells reprograms macrophages to enhance antitumor immunity and synergizes with anti-PD-L1 therapy OA
Cited by 4
Semantic Scholar
Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2 OA
Cited by 3
Semantic Scholar
Identification and Validation of Four Serum Biomarkers With Optimal Diagnostic and Prognostic Potential for Gastric Cancer Based on Machine Learning Algorithms OA
Cited by 3
Semantic Scholar
Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease OA
Cited by 10
Semantic Scholar
Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression OA
Cited by 8
Semantic Scholar
PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance OA
Cited by 34
Semantic Scholar
PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer OA
Cited by 41
Semantic Scholar
Interleukin 32 Promotes Foxp3+ Treg Cell Development and CD8+ T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment OA
Cited by 28
Semantic Scholar
Research Topics
DNA Repair Mechanisms
(21)
Acute Lymphoblastic Leukemia research
(18)
Cancer-related Molecular Pathways
(15)
Microtubule and mitosis dynamics
(11)
Cancer Genomics and Diagnostics
(10)
Frequent Co-Authors
Affiliations
Harvard University
Pfizer (United States)
Shanghai Jiao Tong University
GlaxoSmithKline (United Kingdom)
QIMR Berghofer Medical Research Institute